C4X Discovery Holdings has announced that Eva-Lotta Allan and Natalie Walter have been appointed as Non-Executive Chairman of the Board and Non-Executive Director respectively, with immediate effect.
Eva-Lotta has more than 30 years’ experience in the healthcare industry. During this time, she has been a Senior Executive and Board member at both public and private companies. Most recently, Eva-Lotta was Chief Business Officer (and previously a Board member) at Immunocore, where she held full responsibility for all aspects of business development and played an instrumental role in the $320 million fundraising in 2015. Prior to this, Eva-Lotta served as Chief Business Officer and member of the Executive Committee and Euronext IPO team for Ablynx NV.
Natalie Walter is a corporate finance lawyer with more than 20 years of experience advising on international equity capital markets transactions in the healthcare sector. Most recently, Natalie was an Equity Partner at Covington & Burling LLP. Prior to this, Natalie had been an Equity Partner at Morrison & Foerster LLP and had spent part of her career as a Director and Legal Counsel on the ECM desk at Lehman Brothers. Natalie currently consults as General Counsel to Oxford BioMedica plc, having previously acted as “external” General Counsel to a number of companies and financial institutions, advising boards on a range of strategic, transactional and general corporate finance matters, with particular expertise in advising on deals in the life sciences and med tech sectors.